SMT201500205B - Biomarcatori per valutare la risposta neuropatica periferica a trattamento con un inibitore di prot easoma - Google Patents

Biomarcatori per valutare la risposta neuropatica periferica a trattamento con un inibitore di prot easoma

Info

Publication number
SMT201500205B
SMT201500205B SM201500205T SM201500205T SMT201500205B SM T201500205 B SMT201500205 B SM T201500205B SM 201500205 T SM201500205 T SM 201500205T SM 201500205 T SM201500205 T SM 201500205T SM T201500205 B SMT201500205 B SM T201500205B
Authority
SM
San Marino
Prior art keywords
biomarkers
evaluate
treatment
peripheral neuropathic
proton inhibitor
Prior art date
Application number
SM201500205T
Other languages
English (en)
Italian (it)
Inventor
Nadine Cohen
Reyna Favis
Qingqin Li
Deborah Ricci
Yu Sun
Helgi Van De Velde
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SMT201500205B publication Critical patent/SMT201500205B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201500205T 2009-03-24 2015-08-28 Biomarcatori per valutare la risposta neuropatica periferica a trattamento con un inibitore di prot easoma SMT201500205B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16284809P 2009-03-24 2009-03-24
PCT/US2010/028459 WO2010111361A1 (en) 2009-03-24 2010-03-24 Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor

Publications (1)

Publication Number Publication Date
SMT201500205B true SMT201500205B (it) 2015-10-30

Family

ID=42340761

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500205T SMT201500205B (it) 2009-03-24 2015-08-28 Biomarcatori per valutare la risposta neuropatica periferica a trattamento con un inibitore di prot easoma

Country Status (14)

Country Link
US (1) US9605317B2 (xx)
EP (1) EP2411535B1 (xx)
JP (1) JP5775064B2 (xx)
AU (1) AU2010229988B9 (xx)
CA (1) CA2756193A1 (xx)
DK (1) DK2411535T3 (xx)
ES (1) ES2546879T3 (xx)
HR (1) HRP20150948T1 (xx)
HU (1) HUE027639T2 (xx)
PL (1) PL2411535T3 (xx)
PT (1) PT2411535E (xx)
SI (1) SI2411535T1 (xx)
SM (1) SMT201500205B (xx)
WO (1) WO2010111361A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120295256A1 (en) * 2011-05-18 2012-11-22 Genovive Llc Weight management genetic test systems and methods
CN109468388A (zh) * 2018-12-25 2019-03-15 北京北基医学检验实验室有限公司 一种扩增与运动能力相关基因的引物组及检测试剂盒
CN109750097A (zh) * 2019-01-25 2019-05-14 济南市第四人民医院 一种早期评估紫杉烷类药物化疗不良反应风险的诊断试剂盒
US20220133656A1 (en) * 2019-02-27 2022-05-05 Vanderbilt University Methods of treating trigeminal nerve pain
CN110951855B (zh) * 2019-12-04 2023-02-03 深圳先进技术研究院 缺血性脑卒中溶栓治疗后出血转化风险评估相关基因序列的芯片及其试剂盒
CN110923310B (zh) * 2019-12-24 2023-04-18 广州市妇女儿童医疗中心 用于指导肾病综合征cyp3a5表达型患儿使用他克莫司的多态性位点
CN110904219B (zh) * 2019-12-24 2023-04-18 广州市妇女儿童医疗中心 Myh9及ctla4基因多态性位点在指导肾病综合征患儿使用他克莫司中的应用
CN113528661A (zh) * 2021-02-22 2021-10-22 北京市理化分析测试中心 一种扩增ctla4基因snp位点用引物、检测试剂盒和应用
CN114712511A (zh) * 2022-04-20 2022-07-08 南通大学 Hap1在筛选神经病理性疼痛治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
CA2435124A1 (en) 2001-01-25 2002-08-01 Millennium Pharmaceuticals, Inc. Formulation of boronic acid compounds
KR100653990B1 (ko) 2004-12-29 2006-12-05 주식회사 하이닉스반도체 포토마스크 데이터베이스 패턴의 불량 검사 방법
WO2007067263A2 (en) * 2005-12-06 2007-06-14 The General Hospital Corporation Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
US20100144776A1 (en) * 2006-09-08 2010-06-10 Johann Wolfgang Goethe-Kuniversitaet Frankfurt Am Main Use of snps for the diagnosis of a pain protective haplotype in the gtp cyclohydrolase 1 gene (gch1)

Also Published As

Publication number Publication date
JP2012521758A (ja) 2012-09-20
AU2010229988B2 (en) 2015-08-06
US20100249065A1 (en) 2010-09-30
EP2411535B1 (en) 2015-06-17
EP2411535A1 (en) 2012-02-01
JP5775064B2 (ja) 2015-09-09
PL2411535T3 (pl) 2015-11-30
ES2546879T3 (es) 2015-09-29
SI2411535T1 (sl) 2015-08-31
HRP20150948T1 (hr) 2015-10-09
US9605317B2 (en) 2017-03-28
PT2411535E (pt) 2015-09-11
AU2010229988A1 (en) 2011-10-13
HUE027639T2 (en) 2016-11-28
WO2010111361A1 (en) 2010-09-30
CA2756193A1 (en) 2010-09-30
DK2411535T3 (en) 2015-07-13
AU2010229988B9 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
SMT201500205B (it) Biomarcatori per valutare la risposta neuropatica periferica a trattamento con un inibitore di prot easoma
NL301211I2 (nl) Olipudase alfa
DK3078388T3 (da) Tværbundne hydrogeler til blødvævsforøgelse
BRPI1009551A2 (pt) inibidor de troca de combustível
BR112012000204A2 (pt) apomorfina sublingual.
DK2435742T3 (da) Bøjebegrænser
FR2941796B3 (fr) Ordinateur portable
FI20090054A0 (fi) Kutsupaneeli
SMP201100036B (it) Reattore elettrochimico
GB0915233D0 (en) Monitoring the performance of a computer
BRPI0921038A2 (pt) ácido naftilacéticos
DK2429902T3 (da) Batchopsamler
DK2272751T3 (da) Ror til et skib
NL300948I2 (nl) velmanase alfa
DK2536555T3 (da) Pelletpresse
BR112012001230A2 (pt) célula galvânica
BRPI0924276A2 (pt) célula galvânica
DE112009002496A5 (de) Druckbehälter
BR112012010525A2 (pt) novos processos
FI20095971A0 (fi) Kannettava kosteusmittari
DK2517018T3 (da) Biomarkører
DK2253429T3 (da) Skraldenøgle
DK2261444T3 (da) Mast
TH105053B (th) เครื่องคิดเลข
TH129804B (th) องค์ประกอบที่ใช้ภายนอก